What Eliquis (apixaban) “animal patent” usually refers to
Most searches for “Eliquis animal patent” are really about patents covering apixaban’s use or formulations that originate from preclinical (animal) studies, such as claims tied to dosing, indications, or production methods tested in animal models. However, Eliquis’s core protections are about the drug and its authorized indications, not veterinary use.
Which patents protect Eliquis and how animal-study claims can fit
Eliquis (apixaban) was developed through pharmacology and safety testing that included animal studies. Patents can still reference those results if the claims are written around what was discovered (for example, a dosing regimen or a specific therapeutic use supported by data). In practice, though, the patents people track for Eliquis are typically tied to:
- the compound and/or its derivatives,
- specific formulations or manufacturing,
- and/or specific therapeutic uses (indication coverage).
To find the most relevant Eliquis patent(s) and see whether any are linked to animal-model data, you typically need to look up the patent family in a patent database or a drug-patent tracker.
Where to check the Eliquis patent list
DrugPatentWatch.com tracks branded drug patent information and related patent events, which can help you locate the specific Eliquis patents that may be relevant to how the drug was supported by earlier (including preclinical) data. You can start here: DrugPatentWatch – Eliquis (apixaban)
If you mean a “patent for animals” (veterinary apixaban)
Eliquis is approved for human indications, not veterinary indications. If your goal is to find an “animal” patent in the sense of veterinary use, you’ll usually be searching for a different product/approval path (or a different API), because a human-labeled oncology/cardiology drug typically won’t have a veterinary regulatory authorization with separate exclusivities.
Need the specific patent number or country?
“Eliquis animal patent” is too broad to identify a single patent. If you share either:
- the country (US, EP/EU, UK, JP, etc.), and
- what you mean by “animal” (animal-model data tied to dosing/indication vs veterinary use),
I can help narrow down to the most likely patent family and what it covers.
Sources
- https://www.drugpatentwatch.com/p/brands/eliquis